DOES ADJUVANT CHEMOTHERAPY BENEFIT HIGH-RISK STAGE 2 COLON CANCER: A NOMOGRAM TO PREDICT REDUCTION IN 5-YEAR MORTALITY RISK WITH ADJUVANT CHEMOTHERAPY.

被引：0
|
作者：
Graham, A. E.
Sparks, A.
Umapathi, B.
机构：
来源：
DISEASES OF THE COLON & RECTUM | 2019年 / 62卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P36
引用
收藏
页码：E121 / E122
页数：2
相关论文
共 50 条
  • [1] ADJUVANT CHEMOTHERAPY IN HIGH-RISK STAGE II COLON CANCER.
    Lightner, A.
    Glyn, T.
    Parker, M.
    Tse, C.
    Abdelsattar, Z.
    Larson, D.
    Mathis, K.
    DISEASES OF THE COLON & RECTUM, 2016, 59 (05) : E293 - E293
  • [2] Is the benefit of adjuvant chemotherapy limited to high-risk stage ii colorectal cancer?
    Roberto, M.
    Romiti, A.
    Pilozzi, E.
    Balducci, G.
    Ferri, M.
    Uccini, S.
    Falcone, R.
    Campisi, G.
    Mercantini, P.
    Mazzuca, F.
    Di Pietro, F. R.
    Onesti, C. E.
    Botticelli, A.
    Marchetti, P.
    ANNALS OF ONCOLOGY, 2016, 27
  • [3] Adjuvant chemotherapy for stage II colon cancer: the prognostic value of high-risk features
    Cheong, C.
    Suh, K.
    ANNALS OF ONCOLOGY, 2019, 30
  • [4] Evaluation of the efficacy of adjuvant chemotherapy in patients with high-risk stage II colon cancer
    Cakar, B.
    Varol, U.
    Junushova, B.
    Muslu, U.
    Oner, P. Gursoy
    Surmeli, Z. Gokhan
    Cirak, Y.
    Karaca, B.
    Sezgin, C.
    Karabulut, B.
    Uslu, R.
    JOURNAL OF BUON, 2013, 18 (02): : 372 - 376
  • [5] Comparison of the effect of multidrug and single-drug adjuvant chemotherapy on the 5-year survival outcome of high-risk stage II colon cancer
    Song, Dandan
    Chen, Minyuan
    Meng, Ziqi
    Zhu, Limei
    Liu, Jieyu
    INDIAN JOURNAL OF CANCER, 2024, 61 (03) : 662 - 668
  • [6] Development of a Risk Score and Nomogram to Predict Individual Benefit Attained from the Addition of Adjuvant Chemotherapy in the Treatment of Stage II Colon Cancer
    Nelson, Daniel W.
    Merritt, Clay
    Chang, Shu-Ching
    Grunkemeier, Gary
    Steele, Scott R.
    Goldfarb, Melanie
    JOURNAL OF GASTROINTESTINAL SURGERY, 2021, 25 (01) : 220 - 232
  • [7] Development of a Risk Score and Nomogram to Predict Individual Benefit Attained from the Addition of Adjuvant Chemotherapy in the Treatment of Stage II Colon Cancer
    Daniel W. Nelson
    Clay Merritt
    Shu-Ching Chang
    Gary Grunkemeier
    Scott R. Steele
    Melanie Goldfarb
    Journal of Gastrointestinal Surgery, 2021, 25 : 220 - 232
  • [8] Survival benefit of adjuvant chemotherapy in high-risk patients with colon cancer regardless of microsatellite instability
    Bae, Sung Uk
    Lee, Jong Lyul
    Yang, Chun-Seok
    Park, Eun Jung
    Park, Soo Yeun
    Kim, Chang Woo
    Ji, Woong Bae
    Son, Gyung Mo
    Han, Yoon Dae
    Kim, So Hyun
    Kim, Min Sung
    Park, Youn Young
    Ha Lee, Kyung
    Kim, Chang Hyun
    Ha, Gi Won
    Lee, Jaeim
    Kim, Kyeong Eui
    Jeong, Woon Kyung
    Kim, Duck-Woo
    Baek, Seong Kyu
    EJSO, 2025, 51 (06):
  • [9] Adjuvant chemotherapy for high-risk endometrial cancer
    Pustilnik, T
    Burke, TW
    SEMINARS IN RADIATION ONCOLOGY, 2000, 10 (01) : 23 - 28
  • [10] Adjuvant Chemotherapy in High-risk Stage II Colon Cancer Patients: (Un) common Practice?
    Koebrugge, B.
    Van Steenbergen, L. N.
    Lips, D. J.
    Lemmens, V. E.
    Van der Linden, H. C.
    Pruijt, H. F.
    Liefers, G.
    Van de Velde, C. J.
    Bosscha, K.
    ANNALS OF SURGICAL ONCOLOGY, 2012, 19 : S103 - S103
12345